Discovery | Charles River

Discovery from Charles River is industry-proven in the successful development of potential novel therapies, with over 100 preclinical drug candidates and over 420 patents delivered to our sponsors. Backed by more than 1,100 scientists, our comprehensive, multi-modality integrated portfolio employs the latest technology and platforms to provide chemistry, biology, pharmacology and toxicology services that support clients from the earliest stages of target discovery through IND. Our client-focused, collaborative approach creates true partnerships that anticipate challenges, overcome obstacles, and move us forward together on the journey of getting new drugs to market.